Geron

[anonymous]

So what are the issues? And don't tell me it's the label. The problem isn't that you guys can't sell to 1L or 2L+ non-transfusion dependent patients. The problem is that ya'll aren't even selling well in the 2L+ setting. You guys have a broader label than Luspatercept did in the 2L+ setting at launch. Blaming the label is silly.

This Ahole loser is just one of the many retail LOSERs who are learning what its like to get reamed up the ass JZ style.

 

[anonymous]

This Ahole loser is just one of the many retail LOSERs who are learning what its like to get reamed up the ass JZ style.

I don't have a position yet... Still trying to figure out if there's something terribly wrong with Imetelstat's real world clinical profile (i.e. it's a short), or if mgmt really did just hire a bunch of underperforming reps that they can replace (i.e. it's a long).


Dawn & JZ say it's the later, and doc calls suggest a clinical profile similar to the trial.

Anyway, I think if you can't sell in 2L and 3L setting, you might just be bad at your job.

 

[anonymous]

I don't have a position yet... Still trying to figure out if there's something terribly wrong with Imetelstat's real world clinical profile (i.e. it's a short), or if mgmt really did just hire a bunch of underperforming reps that they can replace (i.e. it's a long).


Dawn & JZ say it's the later, and doc calls suggest a clinical profile similar to the trial.

Anyway, I think if you can't sell in 2L and 3L setting, you might just be bad at your job.

the urinal cake replacement man writes letters suggesting new flavors

 

[anonymous]

So what are the issues? And don't tell me it's the label. The problem isn't that you guys can't sell to 1L or 2L+ non-transfusion dependent patients. The problem is that ya'll aren't even selling well in the 2L+ setting. You guys have a broader label than Luspatercept did in the 2L+ setting at launch. Blaming the label is silly.

The mere fact that you are talking about 2bd, 3rd line setting shows your stupidity. Doctors don't think that way. They think in terms of symptoms and how those symptoms equate to which drug they use. Morons who don't know the market and talk to street want to simplify, 2nd 3rd line because they don't know the market.

Sells are declining because JZ just trashed the people who are out trying to sell the drug. His support of reach and frequency. While not willing to put money in the reps pocket has single handedly told reps to quit selling and look for another job. He told the sales team you are a piece of crap while hiring multiple levels to shield him from talking to the reps and managers.

The culture is now PIPS and unattainable goals that have patients off label attributed to them. Look at last company he was at! He was fired for doing the same thing. If he was in the military, this is the guy who would be shot by his own troups. This company can be successful with a leader and not a micro managing clueless twit that couldn't tell you our drugs indication. Here's a question for the next investors conference call, "Ask him to tell you the indication of the drug" if he can't quote it word for word, stay away from this stock. In fact any company that JZ goes to will never be successful.

 

[anonymous]

The mere fact that you are talking about 2bd, 3rd line setting shows your stupidity. Doctors don't think that way. They think in terms of symptoms and how those symptoms equate to which drug they use. Morons who don't know the market and talk to street want to simplify, 2nd 3rd line because they don't know the market.

Sells are declining because JZ just trashed the people who are out trying to sell the drug. His support of reach and frequency. While not willing to put money in the reps pocket has single handedly told reps to quit selling and look for another job. He told the sales team you are a piece of crap while hiring multiple levels to shield him from talking to the reps and managers.

The culture is now PIPS and unattainable goals that have patients off label attributed to them. Look at last company he was at! He was fired for doing the same thing. If he was in the military, this is the guy who would be shot by his own troups. This company can be successful with a leader and not a micro managing clueless twit that couldn't tell you our drugs indication. Here's a question for the next investors conference call, "Ask him to tell you the indication of the drug" if he can't quote it word for word, stay away from this stock. In fact any company that JZ goes to will never be successful.

Are you mentally handicapped? Of course docs think in terms of what patients are refractory to. Nobody’s using this in ESA naive, and very few are using before luspatercept. So yes, docs are implicitly saying 2L and 3L.

I’ve spoken to a couple (mostly academic) who use before luspatercept in pts with high transfusion burden and VAF… just off of a hunch that suppressing malignant clone will work better. But again, this is them implicitly saying 2L.

Dawn seems competent, but yeah JZ seems clueless. He’s probably the next one out. But anyway, they’re more or less saying a bunch of reps got lazy after easy wins in the academic setting, where imetelstat basically sells itself. Never really reached out to community onc.

Reps who can’t sell this drug in luspatercept & ESA refractory setting should be fired tbh.

 

[anonymous]

Are you mentally handicapped? Of course docs think in terms of what patients are refractory to. Nobody’s using this in ESA naive, and very few are using before luspatercept. So yes, docs are implicitly saying 2L and 3L.

I’ve spoken to a couple (mostly academic) who use before luspatercept in pts with high transfusion burden and VAF… just off of a hunch that suppressing malignant clone will work better. But again, this is them implicitly saying 2L.

Dawn seems competent, but yeah JZ seems clueless. He’s probably the next one out. But anyway, they’re more or less saying a bunch of reps got lazy after easy wins in the academic setting, where imetelstat basically sells itself. Never really reached out to community onc.

Reps who can’t sell this drug in luspatercept & ESA refractory setting should be fired tbh.

Though no actual experience selling Rytelo he fantasizes hoisting a Lombardi size trophy above his head on stage with JZ. Meanwhile, in clothing returns he gleefully sniffs the crotch of returned wear to determine if the item was worn.

 

[anonymous]

Are you mentally handicapped? Of course docs think in terms of what patients are refractory to. Nobody’s using this in ESA naive, and very few are using before luspatercept. So yes, docs are implicitly saying 2L and 3L.

I’ve spoken to a couple (mostly academic) who use before luspatercept in pts with high transfusion burden and VAF… just off of a hunch that suppressing malignant clone will work better. But again, this is them implicitly saying 2L.

Dawn seems competent, but yeah JZ seems clueless. He’s probably the next one out. But anyway, they’re more or less saying a bunch of reps got lazy after easy wins in the academic setting, where imetelstat basically sells itself. Never really reached out to community onc.

Reps who can’t sell this drug in luspatercept & ESA refractory setting should be fired tbh.

Ok clueless, let me explain what I'm talking about. You idiots think all patients are the same, they progress at the same rate, show the same symptoms at the same time. There's alot of things that have to align to get our drug. Idiotic home office people want to think in terms of dividing patients into pure buckets of 1st, second, 3rd line. Go ask a doctor what he uses second line, if he's being honest he will tell you it depends.

What do the platelets look like, transfusion dependent,,, that information is important and it's different for every patient. Doctors think in terms of symptoms and that therapy may change based on such.

 

[anonymous]

Ok clueless, let me explain what I'm talking about. You idiots think all patients are the same, they progress at the same rate, show the same symptoms at the same time. There's alot of things that have to align to get our drug. Idiotic home office people want to think in terms of dividing patients into pure buckets of 1st, second, 3rd line. Go ask a doctor what he uses second line, if he's being honest he will tell you it depends.

What do the platelets look like, transfusion dependent,,, that information is important and it's different for every patient. Doctors think in terms of symptoms and that therapy may change based on such.

For a pt who's still transfusion dependent after ESAs and Luspatercept, what's generally the hold up for trying imetelstat? Compliance with 8 weeks of CBCs? Baseline neutropenia & thrombocytopenia? What's usually the reasoning?

 

[anonymous]

For a pt who's still transfusion dependent after ESAs and Luspatercept, what's generally the hold up for trying imetelstat? Compliance with 8 weeks of CBCs? Baseline neutropenia & thrombocytopenia? What's usually the reasoning?

He dreams in colors and wakes with his fingertips brown and smelly

 

[anonymous]

Without a doubt for many on the commercial team working at Geron has turned out to be the worst career decision we have made. I will be happy to leave this cesspool of exec mgmt team incompetence. You know it's bad when you want to even punch the obnoxious bitch HR woman in the face. Just another clueless Idiot! Tried to bury the survey results, was actually surprised sales wasn't happy about the joke options/RSUs, and this week on the All Hands yammering about more non-sensical BS. She is perfect representative for this joke of a company.

 

[anonymous]

Without a doubt for many on the commercial team working at Geron has turned out to be the worst career decision we have made. I will be happy to leave this cesspool of exec mgmt team incompetence. You know it's bad when you want to even punch the obnoxious bitch HR woman in the face. Just another clueless Idiot! Tried to bury the survey results, was actually surprised sales wasn't happy about the joke options/RSUs, and this week on the All Hands yammering about more non-sensical BS. She is perfect representative for this joke of a company.

She compared “change” to the five stages of grief. RIP Geron. We can deal with change, we actually have a problem with the lack of change on the account of not getting rid of so many incompetent & overpaid idiots with inflated titles who have no idea how to run a commercial org. JZ is dishonest and incompetent, JH is dishonest and incompetent, DW is JZ’s paid puppet who has no clue what she’s doing, but happily assists him in dishonest practices. Compliance/Legal are so underwhelming and under qualified, they have managed to make basic everyday tasks impossible. And don’t get me started on the idiots in Finance who have no idea how a commercial org runs and spends their time denying expense reports all day long. This place will be nonexistent in a year.

 

[anonymous]

Though no actual experience selling Rytelo he fantasizes hoisting a Lombardi size trophy above his head on stage with JZ. Meanwhile, in clothing returns he gleefully sniffs the crotch of returned wear to determine if the item was worn.

He can hoist tiny JZ above his head given he is smaller than the trophy

 

[anonymous]

He can hoist tiny JZ above his head given he is smaller than the trophy

He is a tiny little man with a huge ego that is destroying this place. He screwed up the quotas at his previous employer and we Bri g him her to do the same thing. Send his tiny ass back!! We don’t want him. Truly the worst leader in pharma history. He could not be a VP in primary care let alone the head. #firehisass

 

[anonymous]

She compared “change” to the five stages of grief. RIP Geron. We can deal with change, we actually have a problem with the lack of change on the account of not getting rid of so many incompetent & overpaid idiots with inflated titles who have no idea how to run a commercial org. JZ is dishonest and incompetent, JH is dishonest and incompetent, DW is JZ’s paid puppet who has no clue what she’s doing, but happily assists him in dishonest practices. Compliance/Legal are so underwhelming and under qualified, they have managed to make basic everyday tasks impossible. And don’t get me started on the idiots in Finance who have no idea how a commercial org runs and spends their time denying expense reports all day long. This place will be nonexistent in a year

Hmmm would you be willing to talk to a hedge fund guy about what's going on there? I'll keep you completely anon.

 

[anonymous]

Hmmm would you be willing to talk to a hedge fund guy about what's going on there? I'll keep you completely anon.

This board is for sales. If you're a hedge fund or any other type of non-retail investor and you're not purchasing IQVIA data then you deserve what you get. The retail investors are schmucks who deserve to bleed out their assholes.

 

[anonymous]

This board is for sales. If you're a hedge fund or any other type of non-retail investor and you're not purchasing IQVIA data then you deserve what you get. The retail investors are schmucks who deserve to bleed out their assholes.

We get IQVIA data. We just want to figure out what's going behind the scenes. The earnings call was a mess and management isn't offering a coherent narrative around what went wrong and what they plan to fix in 1x1s either.

I'm tempted to long b/c of how much the stock's come down but would like to get an idea of whether this is a fixable problem or not first.

 

[anonymous]

We get IQVIA data. We just want to figure out what's going behind the scenes. The earnings call was a mess and management isn't offering a coherent narrative around what went wrong and what they plan to fix in 1x1s either.

I'm tempted to long b/c of how much the stock's come down but would like to get an idea of whether this is a fixable problem or not first.

Obviously you didn't listen closely JZ is going to fix this with more "reach and frequency " hes going to give higher goals that are out of indication, this saves the company so much money not having to pay bonus. Here's his next move that wasn't mentioned. If a rep doesn't hit their goal he will instruct the manager to put them on a plan.

JZ is brilliant telling your sales team they suck and underperformed, what do you think will happen? If I was an investor and saw this strategy, I would definitely be long on the stock.

 

[anonymous]

Hmmm would you be willing to talk to a hedge fund guy about what's going on there? I'll keep you completely anon.

He inflated goals to align with his grossly overstated numbers, putting the company at risk of promoting off label. No one trusts him and rightfully so. Ask the board why a company in their first year of launch approved him to pad himself with so many inflated titles and overpaid and unnecessary roles. How many VPs and layers does one need to hire to tank stock and eff up a launch in first year? The answer I guess is as many as it takes for him to hire his own chosen incompetent scumbags who will carry out his incompetence. JH and DW willingly went along with this and began trying to intimidate employees who spoke up regarding the overstated goals. He has no idea what he’s doing and what makes it worse is that he is malicious and dishonest. He’s running the company dry. This company will fail as long as he and his chosen minions remain.

 

[anonymous]

The dimwit Jims lost the sales team in record time! Unrealistic goals so, most are looking for jobs. Only people dumber than the jims is the company's board who hired them

 

[anonymous]

Obviously you didn't listen closely JZ is going to fix this with more "reach and frequency " hes going to give higher goals that are out of indication, this saves the company so much money not having to pay bonus. Here's his next move that wasn't mentioned. If a rep doesn't hit their goal he will instruct the manager to put them on a plan.

JZ is brilliant telling your sales team they suck and underperformed, what do you think will happen? If I was an investor and saw this strategy, I would definitely be long on the stock.

If I were an investor, this is what I would look for from a pharma company. The sales force is the major driver of sales, especially at launch. But, you have to have the good reps, these reps are extremely hard to find. What do those look like. Most have over 10 years of Oncology. They constantly keep up with the clinical data and most do this on their own. They read the NCCN, ASCO reviews, reimbursement, GPO, etc... These reps are vital and are the highest paid in the industry. Their confidence in the clinical understanding of the data gains them access to doctors who have spent years training and it's these reps that have to convince the physician that their product is the best for their patients. One challenge for a company their confidence and demand at other companies is high.

A company that gets these reps has to pay them and make the bonus attractive to keep them. You want these reps excited to go out and challenge doctors every day to use the drug they represent. Good companies understand this and they entertain them at meetings and encourage recognition. Good companies want them to leave a meeting feeling energized and excited to get up in the morning to push the product they sale. They are willing to take a chance on a start up because they know there is a financial incentive, stock potential, and a culture of being part of the best.

Now, what happens if you hire these individuals, they attend a meeting and the meeting has zero recognition. They are preached at and shamed by telling them that they failed at launch. They get goals that are so big the opportunity for financial success is limited. How do you think that rep feels when they leave that meeting?

When that rep get's back home, they know they can't hit their goal and they feel the pressure of not having a value to the company. A recruiter calls and guess what, they answer the phone. They act like everything is fine and then the leave. Many leave at the same time. You are still in a launch and nobody is selling your drug. By the time those leave and you hire new reps that at this point are the bottom of the barrel do you think that company will be successful? Smart leaders understand this, so my question to you, "Is JZ a smart leader?"